Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,560 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07534397Recruiting
Brain stimulation for thinking and movement in Parkinson's
This study tests whether a gentle electrical current applied to the scalp can improve thinking, language, and movement problems in people with Parkinson's disease. You will receive either real or pretend stimulation to see if it helps.
Richardson, TexasAges 50–90 - NCT07537426Recruiting
Acupuncture for Dry Eyes After Facial Paralysis
This trial tests whether tiny acupuncture needles placed under the skin can help relieve dry eyes and other eye discomfort that develops after long-lasting facial paralysis. The goal is to see if this treatment can improve symptoms when standard care hasn't worked well enough.
Hangzhou, ZhejiangAges 18–65 - NCT06751797Recruiting
Balance confidence and fear of falling in Parkinson's
This study looks at how confident people with Parkinson's are in their balance and whether fear of falling (kinesiophobia) affects their daily life. The goal is to better understand these factors so that future treatments can help people stay active and safe.
Istanbul, BeylikdüzüAges 50–80 - NCT07531732Recruiting
Self-Awareness and Social Thinking in Brain Diseases
This study explores how awareness of oneself and the ability to understand others' thoughts relates to two types of brain diseases: frontotemporal dementia (a disease affecting personality and behavior) and Alzheimer's disease. The research may help doctors better understand these conditions and improve care.
ParisAges 50–80 - NCT07533799Recruiting
Swedish BioFINDER Sleep Study: Brain imaging in RBD and Parkinson's
This study examines brain changes in people with REM sleep behavior disorder (acting out dreams during sleep) and early Parkinson's disease using brain imaging scans. Researchers want to understand how sleep problems relate to Parkinson's development and find early warning signs.
MalmöAges 50–100 - NCT07525843Recruiting
Well-being education program for teens with heart disease
This study tests whether a special education program about managing emotions and stress helps teenagers with moderate-to-severe congenital heart disease (a heart condition from birth) feel better and cope with their condition. Participants attend sessions and complete surveys over time.
Stanford, CaliforniaAges 12–17 - NCT07531342Recruiting
Brain Stimulation and Diet for Severe Crohn's Disease
This study tests whether repetitive transcranial magnetic stimulation (a non-invasive brain treatment) combined with an anti-inflammatory diet can help people with severe, treatment-resistant Crohn's disease feel better. The brain stimulation uses magnetic pulses on the scalp to reduce inflammation and improve symptoms.
Giza, Giza GovernorateAges 40–60 - NCT07530757Recruiting
SuperCAP: An App Program to Help Post-COVID Brain Fog
This study tests a smartphone app designed to help people with long-COVID improve their thinking and daily activities. You'll use the app about 15 minutes a day, 5 days a week, to work on cognitive skills and functioning.
Badalona, BarcelonaAges 18–65 - NCT07525973Enrolling by invitation
Eye exercises for Parkinson's disease
This study tests whether doing specific eye exercises can help people with Parkinson's disease. The exercises are done three times a week for 8 weeks at a study center.
IsfahanAges 18–80 - NCT07521280Recruiting
Personalized rehabilitation for knee or heel pain in young athletes
This study tests a personalized exercise program for teenagers with knee or heel pain caused by growth-related conditions like Osgood-Schlatter or Sever's disease. The program aims to reduce pain and help you get back to sports safely.
Gdansk, Debinki 7Ages 10–17 - NCT07518290Recruiting
Home brain stimulation for Parkinson's disease movement symptoms
This trial tests a non-invasive brain stimulation technique called transcranial temporal interference stimulation (TTIS) that you can use at home with remote supervision. It aims to improve movement problems like stiffness, tremor, and slowness in people with mild-to-moderate Parkinson's disease.
Shanghai, Shanghai MunicipalityAges 40–80 - NCT07518472Recruiting
Box Breathing and Lung Exercises for COPD Shortness of Breath
This study tests whether a simple breathing technique called box breathing, combined with short-term breathing exercises, can help reduce shortness of breath and improve daily functioning in people with mild COPD (chronic obstructive pulmonary disease).
IslamabadAges 40–65 - NCT06757829Recruiting
Lung function in sickle cell: testing Acu-TENS therapy
This study tests if a gentle electrical nerve stimulation treatment (called Acu-TENS) can help improve your lung function. It's for people with sickle cell disease who are not currently in pain or have other major health issues.
Dokki, Giza GovernorateAges 20–50 - NCT05801380Recruiting
Tracking how well a medicine works in Alzheimer’s patients
This study looks at how effective a treatment is in people newly diagnosed with mild to moderate Alzheimer’s disease. It also involves health and medication history checks and likely stool (fecal) sample collection to monitor effects.
Manila, National Capital RegionAges 65 years+ - NCT06579677Recruiting
Watching small blood vessels in the brain over time
This study watches how small blood vessels in the brain change over time. It may help doctors understand brain health as people age.
Beijing, Beijing MunicipalityAges 50–75 - NCT07514338RecruitingPhase 2
Long-term safety study of KL1333 for mitochondrial disease
This is a follow-up study for patients who completed a previous trial (FALCON) testing KL1333, an experimental medicine for primary mitochondrial disease—a condition where cells don't produce enough energy. The study tracks how safe and effective the treatment remains over time.
Akron, OhioAges 18 years+ - NCT07513181RecruitingPhase 2
Testing ATH-063 for Hard-to-Treat Ulcerative Colitis
This study tests a new drug called ATH-063 to see if it can help people with moderate-to-severe ulcerative colitis (a condition causing inflammation and bleeding in the colon) who haven't responded well to previous biologic treatments. The goal is to find out if this new drug is safe and effective.
Miami, FloridaAges 18–75 - NCT07510191RecruitingPhase 4
Comparing two ways to treat Crohn's disease if TNFi isn't working well
This trial tests if adding a low dose of a newer pill (upadacitinib) to your current TNF inhibitor (TNFi) works better than increasing the dose of your TNFi alone. It is for people with Crohn's disease who have had some improvement on their TNFi but still have active disease.
Guangzhou, GuangdongAges 18–65 - NCT07509606Recruiting
Whole body vibration for healthy adults and COPD patients
This study tests if a vibrating platform can help people with COPD and healthy adults. You stand on a machine that gently vibrates to improve muscle function and breathing.
TainanAges 18 years+ - NCT07513844Recruiting
Ultrasound Treatment for Huntington's Disease Movement Symptoms
This trial tests a new focused ultrasound technique aimed at reducing involuntary movements (chorea) in people with Huntington's disease. The treatment targets a specific brain region and may help improve movement control and quality of life.
Fuzhou, FujianAges 18–75 - NCT07512362RecruitingPhase 2
Stem cells and antibodies for early Alzheimer's disease
This study tests whether human stem cells, combined with your existing Alzheimer's medication (Leqembi or Kisunla), can help slow memory loss and improve daily functioning in people with mild cognitive impairment or early Alzheimer's. You would receive a stem cell infusion as an add-on to your current treatment.
Miami, FloridaAges 55–90 - NCT06535308RecruitingPhase 1
Testing a new Alzheimer's drug for moderate disease
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Seoul, Jongno-guAges 19–45 - NCT07500506RecruitingPhase 3
Safety of a fifth dose of the Lyme disease vaccine
This study is for people who have already received four doses of the Lyme vaccine (VLA15) in a previous study. It tests whether a fifth dose is safe and helps the body build more protection against Lyme disease.
Bangor, MaineAges 7 years+ - NCT07507201RecruitingEarly Phase 1
Car-T cells for autoimmune diseases like lupus
This trial tests whether specially-engineered immune cells (CAR-T cells) can help people with certain autoimmune diseases that haven't gotten better with standard treatments. The cells are designed to target and remove faulty B cells that are causing the immune system to attack the body.
Hangzhou, ZhejiangAges 3 years+
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,560 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.